相关实验视频
Updated: Jul 17, 2025
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.4K
2023年加拿大炎症性肠病的影响:COVID-19和IBD
Gilaad G Kaplan1, M Ellen Kuenzig2,3, Joseph W Windsor1
1Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Journal of the Canadian Association of Gastroenterology
|September 7, 2023
概括
患有炎症性肠病 (IBD) 的人面临与一般人群相同的COVID-19风险. 维持IBD疗法和疫苗接种对于管理严重结果至关重要.
科学领域:
- 胃肠道学和免疫学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- COVID-19大流行对炎症性肠病 (IBD) 社区产生了重大影响,最初对SARS-CoV-2的影响存在不确定性,特别是在免疫功能低下的患者中.
- 科学文献的快速扩展需要为IBD患者制定临床指导和疫苗推.
研究的目的:
- 总结当前的知识,并为IBD患者提供COVID-19管理的指导.
- 在不断变化的流行病信息中,为患者,护理人员,医疗保健提供者和决策者提供信息.
主要方法:
- 关于COVID-19和IBD的新兴科学文献的审查和综合.
- 成立一个工作组 (加拿大冠状炎和结肠炎COVID-19和IBD工作组) 来处理信息并提出建议.
- 在IBD人群中分析疫苗的有效性和安全性.
主要成果:
- 在IBD患者和普通人群中,感染COVID-19的风险类似.
- 在IBD患者中,严重的COVID-19风险与晚年,并发症,活跃疾病爆发和高剂量普得尼松使用有关.
- 三剂量mRNACOVID-19疫苗方案在IBD患者中引起了强大的抗体反应,其安全性与一般人群相似.
- 建议持续使用维护疗法,包括生物药物,以预防严重的COVID-19结果.
结论:
- 肠胃炎症患者没有增加COVID-19感染的风险,但在爆发或高剂量免疫抑制期间需要谨慎管理.
- 包括增强剂在内的COVID-19疫苗接种对IBD患者来说是安全有效的,可以保护他们免受严重疾病的侵害.
- 进一步的研究对于了解COVID-19及其对IBD患者的治疗方法的长期影响至关重要.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
285
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
285
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
354
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
213
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
01:21Inflammatory Bowel Disease V: Surgical Management
167
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
167
01:17Chronic Bowel Disorders: Introduction
478
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
478